Fundraising Fox

Michael Henderson

Chief Executive Officer and Director at Apogee Therapeutics

San Francisco Bay Area

Find your path to Michael

959 people in our graph share verified history with Michael β€” schools, employers, funds. One of them is your warm intro.

Kike MirallesunlockedMichael: together at McKinsey & Company (2016)
Γ—8Michael: together at McKinsey & Company
Γ—3Michael: together at Massachusetts General Hospital

About

Michael Henderson, M.D., is the Chief Executive Officer of Apogee Therapeutics, a biotechnology company developing therapies for immunological and inflammatory disorders. His industry experience includes involvement in the creation of more than 20 companies, the launch of 40 drug development programs, and two FDA approvals. He holds a B.A. from Harvard University and an M.D. from Stanford University.

Chief Executive Officer and Director at Apogee Therapeutics

Intro paths

β†’

In turn, Michael can intro founders to Apogee Therapeutics's investors below.

Experience

  1. Apogee TherapeuticsChief Executive Officer at Apogee Therapeuticscurrent2022 β€” presentSan Francisco Bay Area
  2. BridgeBioChief Business Officer2019 β€” 2022San Francisco Bay Area
  3. BridgeBioSVP of Asset Acquisition, Strategy, & Operations2017 β€” 2022San Francisco Bay Area
  4. BridgeBioVP of Asset Acquisition, Strategy, & Operations2016 β€” 2022Palo Alto
  5. Origin BiosciencesCBO2018 β€” 2022San Francisco Bay Area
  6. Adrenas TherapeuticsMember Board Of Directors2017 β€” 2022Greater Boston
  7. QED TherapeuticsActing CEO2017 β€” 2022Palo Alto
  8. Quartz TherapeuticsMember Board Of Directors2016 β€” 2022San Francisco Bay Area
  9. TheRas TherapeuticsMember Board Of Directors2016 β€” 2022San Francisco Bay Area
  10. McKinsey & CompanySenior Associate2015 β€” 2016
  11. McKinsey & CompanySummer Associate2014Silicon Valley
  12. GE VenturesAssociate Intern - Healthcare Team2014Menlo Park, California
  13. Kaiser Permanente Strategic ServicesProject Manager2013 β€” 2014
  14. PellePharmCo-Founder2011 β€” 2014Palo Alto
  15. Massachusetts General HospitalResearcher2007 β€” 2011
  16. Harvard College Global Health ReviewCo-Founder & Co-Editor-in-Chief2008 β€” 2010
  17. Oklahoma Medical Research FoundationInvestigative Researcher2006 β€” 2007

Skills & more

Research61Neuroscience13Grant Writing40Data Analysis46Science9Qualitative Research5Molecular Biology5Community Outreach6Statistics3Biotechnology6Entrepreneurship4Strategy9
+4 moreLeadershipPublic SpeakingManagementStata

Languages English Β· Spanish

From Michael's professional profile.

Frequently asked questions

Who is Michael Henderson?
Michael Henderson, M.D., is the Chief Executive Officer of Apogee Therapeutics, a biotechnology company developing therapies for immunological and inflammatory disorders. His industry experience includes involvement in the creation of more than 20 companies, the launch of 40 drug development programs, and two FDA approvals. He holds a B.A. from Harvard University and an M.D. from Stanford University.
Where does Michael Henderson work?
Michael Henderson is Chief Executive Officer and Director at Apogee Therapeutics.
Where did Michael Henderson go to school?
Michael Henderson studied at Harvard University (Global Health); Stanford University School of Medicine (MD, Concentration in Health Policy); Stanford University Graduate School of Business (Ignite Program).

Same school

Shared employers